The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year.
Recent Posts
- Trump’s Tariffs Could Raise Prices on Many Consumer Goods
- Effect of U.S. Tariffs on British Companies ‘Milder Than Feared,’ Central Bank Says
- Southeast Asia Looks for Clarity From U.S. on ‘Rules of Origin’
- What Will Be the Next Big Media Deal?
- California Start-Up Will Buy Assets of Bankrupt Swedish Battery Maker
Recent Comments
No comments to show.
Recent Posts
1
Trump’s Tariffs Could Raise Prices on Many Consumer Goods
Post Date
20 mins ago
2
Effect of U.S. Tariffs on British Companies ‘Milder Than Feared,’ Central Bank Says
Post Date
1 hour ago
3
Southeast Asia Looks for Clarity From U.S. on ‘Rules of Origin’
Post Date
2 hours ago
4
What Will Be the Next Big Media Deal?
Post Date
2 hours ago
5
California Start-Up Will Buy Assets of Bankrupt Swedish Battery Maker
Post Date
2 hours ago
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5
Grid Posts
Trump’s Tariffs Could Raise Prices on Many Consumer Goods
Post Date
20 mins ago
Effect of U.S. Tariffs on British Companies ‘Milder Than Feared,’ Central Bank Says
Post Date
1 hour ago
Southeast Asia Looks for Clarity From U.S. on ‘Rules of Origin’
Post Date
2 hours ago
What Will Be the Next Big Media Deal?
Post Date
2 hours ago
California Start-Up Will Buy Assets of Bankrupt Swedish Battery Maker
Post Date
2 hours ago